Caption Management »

Monte Rosa Therapeutics shares owned by Caption Management

Quarter-by-quarter ownership of Monte Rosa Therapeutics (GLUE) shares owned by Caption Management from 13F filings

Historical chart of Caption Management investment in Monte Rosa Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Monte Rosa Therapeutics held by Caption Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Monte Rosa Therapeutics by Caption Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $2.4M 423k 5.65
2023-09-30 $1.7M 361k 4.79

More positions owned by Caption Management

Cytokinetics Com New Call Option (CYTK)
Verizon Communications Put Option (VZ)
Metropcs Communications Call Option (TMUS)
Citigroup Com New Put Option (C)
Mondelez Intl Cl A Put Option (MDLZ)
stock Call Option
Spdr Ser Tr S&p Regl Bkg Put Option (KRE)
Kenvue Call Option (KVUE)
Palo Alto Networks Put Option (PANW)
Sarepta Therapeutics Call Option (SRPT)
Spdr Ser Tr S&p Biotech Call Option (XBI)
United States Steel Corporation Call Option (X)
Tal Education Group Sponsored Ads Call Option (TAL)
Zillow Group Cl C Cap Stk Call Option (Z)
Agnico Call Option (AEM)

View all positions for Caption Management

Top funds holding Monte Rosa Therapeutics

NEA Management Company
T. Rowe Price Associates
Baker Bros. Advisors
venBio Select Advisor
Vanguard Group
Aisling Capital Management
Alphabet
Citadel Advisors
Casdin Capital
Caption Management
Charles Schwab Investment Management
TD Asset Management
Candriam Luxembourg S.C.A.
Bank of New York Mellon
Bank of America Corporation

View all funds holding Monte Rosa Therapeutics